Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), today announced the appointment of Mark W. Feinberg, M.D. as Chief Medical Advisor. Dr. Feinberg will guide Bluejay’s clinical development programs and provide strategic medical and scientific leadership to the Company.
